Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda

Ezekiel Mupere1, Charles Karamagi, George Zirembuzi

  • 1Department of Paediatrics and Child Health, Faculty of Medicine, Makerere University, Kampala, Uganda. mupez@yahoo.com

Vaccine
|March 24, 2006
PubMed

Insights

Measles vaccination effectiveness in Uganda was 74%, lower than anticipated. This suggests a need to improve vaccine cold chain and consider additional measles vaccination opportunities.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Measles remains a significant public health challenge in Uganda.
  • Effective measles control relies heavily on successful vaccination programs.

Purpose of the Study:

  • To assess the effectiveness of measles vaccination among household contacts in Uganda.
  • To identify potential factors contributing to lower-than-expected vaccine effectiveness.

Main Methods:

  • A prospective study was conducted involving household contacts aged 9-59 months.
  • Index measles cases were identified from Kampala hospitals in 1999.
  • Measles diagnosis rates were compared between vaccinated and unvaccinated contacts.

Main Results:

  • Measles incidence was significantly higher in unvaccinated contacts (86%) compared to vaccinated contacts (23%).
  • The calculated measles vaccination effectiveness was 74% (95% CI; 64-81).
  • This effectiveness rate was lower than generally expected.

Conclusions:

  • The study highlights a potential need to strengthen the vaccine cold chain in Uganda.
  • Consideration should be given to implementing a second opportunity for measles vaccination.
  • Supplementary immunization activities or routine program integration may be necessary.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...